Cell chassis as foundational engineering
A chassis is a minimal, well-characterized cell background — non-essential genomic burden removed, competing metabolic drains silenced, and host regulatory networks profiled so your incoming genetic circuit lands in a predictable environment.
The hidden cost of a poorly chosen chassis
Every synthetic biology program begins with a host organism — the chassis into which the new pathway or circuit is introduced. In most R&D workflows, that decision is made in an afternoon: pull a glycerol stock from the inventory, confirm it's competent for your vector system, start cloning. The strain choice is treated as a solved problem.
It rarely is. Standard strains like E. coli MG1655 or BL21 carry decades of evolutionary optimization for their native lifestyles, not for your biosynthetic target. Native regulatory circuits — sigma factor competition, carbon catabolite repression, the acetate overflow that begins the moment glucose uptake saturates — actively work against high-flux pathway performance. Precursor pools are thin. Export machinery moves your product in the wrong direction. Plasmid burden increases as construct complexity grows, and growth rate declines in ways that are hard to attribute until you've run a proteomics screen you weren't planning.
By the time a team recognizes the chassis as the rate-limiting step, several months of strain debugging typically separate them from the pathway work they came to do.
Chassiscell treats the chassis as an engineering object in its own right. We apply the same rigor to host design — flux balance modeling, rational deletion of non-essential gene clusters, orthogonal regulatory element selection — that most programs apply to pathway design. The result is a genetic background that is characterized before you receive it and designed to be compatible with the circuit you're building.
We do not sell generic competent cells. We build chassis matched to program requirements: specific organisms, specific pathway classes, specific production conditions. If a standard strain is genuinely the right choice for your program, we will tell you that in scoping.
Chassis across the tree of life
Design. Build. Characterize.
Chassis Design
Constraint-based metabolic reconstruction and flux balance analysis before any bench work. We identify competing pathways, transcriptional interference risks, and host compatibility constraints specific to your target compound and organism. Genome-scale models (COBRA-compatible) guide deletion targeting and plasmid copy number decisions.
Precision Build
Modular assembly using a defined parts library compatible with MoClo and Golden Gate standards. Genome edits are executed via CRISPR/Cas9 with confirmed scar-free deletion verification. Minimal footprint approach — we target only the genes the modeling stage identifies, not a broad clean-sweep that introduces unpredictable phenotypes.
Functional Characterization
Growth kinetics, yield and titer measurements, plasmid retention assays, and stress-tolerance profiling under partner-relevant conditions. Full characterization package delivered alongside the chassis — including condition-matched metabolic flux data so your team understands the cellular economics of what you're receiving.
Technical foundations
Current capabilities across our chassis development pipeline. These are the actual parameters we work within — not aspirational roadmap items.
| Genome reduction | Up to 30% non-essential gene deletion in core E. coli K-12 chassis — IS element removal, prophage excision, and targeted metabolic gene deletions confirmed by whole-genome resequencing. Validated for comparable growth rate under fed-batch conditions. |
|---|---|
| Plasmid compatibility | Broad-host-range vector systems; CRISPRi-compatible knockdown strains for tunable suppression without permanent deletion. MoClo- and Golden Gate-compatible parts tested against our chassis backgrounds prior to delivery. |
| Metabolic modeling | Constraint-based reconstruction and analysis (COBRA-compatible); flux balance analysis and flux variability analysis to predict and bound pathway yields before construction. Models built on published genome-scale reconstructions, refined with measured uptake rates. |
| Characterization output | Growth curves (batch and fed-batch), proteomics snapshot, plasmid retention assay, and isotope-labeling-derived metabolic flux data provided with each chassis delivery. Delivered as structured data files — not just colony counts and a growth curve image. |
Interested in a technical conversation?
We're open to discussing chassis requirements, organism compatibility, and what a Chassiscell collaboration structure would look like for your specific program — whether you're at pathway design stage or already debugging expression instability.
Contact the Lab